Rapport
The Health Benefits of Rotavirus Immunization for Children in Palestine: Results of a Vaccine Impact Analysis
Rotavirus vaccination in Palestine has significantly reduced the burden of diarrhea among children, and the benefits were sustained through a vaccine product switch.
In 2018, the Palestinian Ministry of Health (MOH) decided to switch from ROTARIX® to ROTAVAC® in their immunization program. Building on previous surveillance work, PATH worked with the Rostropovich Vishnevskaya Foundation and the MOH to study health indicators for two years following the switch to ROTAVAC in order to confirm the continued health benefits of the rotavirus immunization program. This brief presents the results of this impact analysis, which confirm the significant benefit that the rotavirus immunization program has had on reducing the disease burden caused by rotavirus in Palestine.
Corporate author(s): PATH, Rostropovich Vishnevskaya Foundation, Palestinian Ministry of Health
Publication date: August 2021
Langues
- Russe
Année de publication
2021
Type
Rapport
Catégories
- Gestion de programme
Maladies
- Rotavirus
Mots-clés
- Introduction de nouveaux vaccins
Régions de l'OMS
- Région de la Méditerranée orientale
PORTFOLIO-LESSONS
Vous pouvez trouver plus d’informations sur "PORTFOLIO-LESSONS" dans les rubriques suivantes :
| Titre | Auteur | Année | Type | Langue |
|---|---|---|---|---|
| The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in Zambia | Kirstin Krudwig, Barbara Knittel, Ali Karim, Natasha Kanagat, Wendy Prosser, Guissimon Phiri, Frances Mwansa, Robert Steinglass | 2020 | Journal article | Anglais |
| A Switch for Sustainability in Ghana's Rotavirus Vaccine Program | George Armah | 2020 | Case study | Anglais |
| Introducing 5-dose Measles-Rubella Vaccine Vials in Zambia: Research Findings | Dose Per Container Partnership (DPCP), JSI Research & Training Institute, Inc | 2019 | Case study | Anglais |
| The switch from ROTARIX to ROTAVAC in Ghana: Answers to four key questions | PATH | 2022 | Report | Anglais |
| Economic Implications of Switching Rotavirus Vaccine Products in Palestine's Immunization Program | PATH | 2020 | Case study | Russe |
| The Health Benefits of Rotavirus Immunization for Children in Palestine: Results of a Vaccine Impact Analysis | PATH, Rostropovich-Vishnevskaya Foundation, Palestine Ministry of Health | 2021 | Report | Russe |
